deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT02049489

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Immunological Targeting of CD-133 in Recurrent Glioblastoma: A Multi-center Phase I Translational and Clinical Study of an Autologous CD-133 DC Vaccine

Sponsor: Precision Life Sciences Group

Conditions Glioblastoma Multiforme
Interventions ICT-121 DC vaccine
Updated 8 times since 2017 Last updated: Aug 9, 2018 Started: Dec 31, 2013 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Glioblastoma Multiforme and is currently completed. Precision Life Sciences Group leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Jul 2019 · 10 months · monthly snapshotCompleted~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jul 2019 — Jan 2021 [monthly]

    Completed PHASE1

  5. Sep 2018 — Jul 2019 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE1

  2. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

  3. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Precision Life Sciences Group
Data source: Precision Life Sciences Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations